Physician profile
Ira Goldberg
NPI 1821145905
$5,492.27
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,411 · 2020: $22.75 · 2021: $1,900 · 2022: $16.58 · 2023: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,874.27 | 2019 | |
| Akcea Therapeutics, INC. | $1,880.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $242.09 | 2019 | |
| Novo Nordisk INC | $161.44 | 2019-2022 | |
| Esperion Therapeutics, INC. | $118.00 | 2023 | Nexletol |
| Merck Sharp & Dohme LLC | $112.53 | 2019 | |
| Amgen INC. | $80.07 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $23.87 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.